4411 | VOIS 003 X 0031 | kaiser | 03/27/2015 10:34:43 AM |
4498 | $GFOX 0032 | kaiser | 02/08/2016 9:44:59 AM |
4497 | $GFOX 0028 | kaiser | 02/08/2016 9:40:20 AM |
4496 | $GFOX 0025 | kaiser | 02/08/2016 9:34:20 AM |
4495 | $GFOX 0023 nice 8-k out. | kaiser | 02/08/2016 9:30:36 AM |
4494 | $GEQU .0285 chart setting up very well. Bollinger | kaiser | 02/08/2016 9:26:15 AM |
4493 | $ICNV 0037 | kaiser | 02/04/2016 3:05:02 PM |
4492 | $FLCR 0028 | kaiser | 02/04/2016 2:18:43 PM |
4491 | $FLCR 0024 | kaiser | 02/04/2016 2:00:38 PM |
4490 | $ICNV 0032 | kaiser | 02/04/2016 1:33:50 PM |
4489 | $FLCR 0022 should be a nice mover from | kaiser | 02/04/2016 10:44:21 AM |
4488 | $ICNV 0027 | kaiser | 02/04/2016 10:12:21 AM |
4487 | $ICNV 0025 X 0026 | kaiser | 02/04/2016 10:07:08 AM |
4486 | $ICNV 0024 X 0025 | kaiser | 02/04/2016 10:02:51 AM |
4485 | $GEQU .03 | kaiser | 02/04/2016 9:42:31 AM |
4484 | $PGEI 0009 hitting. Company should have some very | kaiser | 02/04/2016 9:38:59 AM |
4483 | $ICNV 0022 X 0023 | kaiser | 02/04/2016 9:37:26 AM |
4482 | $GEQU .0297 nice article about the company here. | kaiser | 02/04/2016 9:35:31 AM |
4481 | $DEAC 0014 | kaiser | 02/04/2016 9:31:15 AM |
4480 | $DEAC 0012 X 0013 | kaiser | 02/03/2016 3:57:34 PM |
4479 | $PGEI 0009 | kaiser | 02/03/2016 3:51:28 PM |
4478 | $PGEI 0008 | kaiser | 02/03/2016 3:23:41 PM |
4477 | $DEAC 001 should be a nice bounce play | kaiser | 02/03/2016 3:15:11 PM |
4476 | $PGEI 0007 | kaiser | 02/03/2016 2:44:02 PM |
4475 | $ICNV 002 X 0023 | kaiser | 02/03/2016 2:33:50 PM |
4474 | $GEQU .0282 X .0299 | kaiser | 02/03/2016 2:30:01 PM |
4473 | $GEQU .0287 not much below .03 | kaiser | 02/03/2016 2:21:24 PM |
4472 | $ICNV 002 X 0022 | kaiser | 02/03/2016 2:11:03 PM |
4471 | ICNV 002 | kaiser | 02/03/2016 1:46:18 PM |
4470 | $GEQU .027 X .0289 bidders moving | kaiser | 02/03/2016 1:43:26 PM |
4469 | $ICNV 0017 new filing out. | kaiser | 02/03/2016 1:41:02 PM |
4468 | $PGEI 0005 X 0006 | kaiser | 02/03/2016 1:24:06 PM |
4467 | $PGEI 0005 nice buying. Company should have some | kaiser | 02/03/2016 1:19:43 PM |
4466 | $GEQU .026 X .029 | kaiser | 02/03/2016 9:51:22 AM |
4465 | $ICNV 002 looks ready for a nice move up. | kaiser | 02/03/2016 9:48:37 AM |
4464 | $GEQU .025 very nice 8-k filing out. | kaiser | 02/03/2016 9:44:27 AM |
4463 | $SREH 0004 nice news out today. | kaiser | 02/02/2016 11:39:15 AM |
4462 | $URBF 003 hitting | kaiser | 02/01/2016 10:54:35 AM |
4461 | $GEQU .0314 company should have some very nice | kaiser | 02/01/2016 10:43:17 AM |
4460 | $PGEI 0007 X 0009 | kaiser | 01/29/2016 1:31:29 PM |
4459 | $ICNV 0034 | kaiser | 01/29/2016 12:26:42 PM |
4458 | $ICNV 003 | kaiser | 01/29/2016 10:48:32 AM |
4457 | $PGEI 0005 X 0006 | kaiser | 01/29/2016 10:24:46 AM |
4456 | $ICNV 0021 X 0026 should be a nice bounce play | kaiser | 01/29/2016 10:07:55 AM |
4455 | $URBF 0028 X 003 | kaiser | 01/29/2016 10:06:11 AM |
4454 | $PGEI 0005 getting some volume. Company should | kaiser | 01/29/2016 10:04:56 AM |
4453 | URBF 0025 looks ready for another move up. | kaiser | 01/29/2016 9:58:07 AM |
4452 | $DMHI 0009 getting some volume | kaiser | 01/28/2016 2:18:03 PM |
4451 | $MXMG 0045 | kaiser | 01/28/2016 1:22:52 PM |
4450 | $MXMG 004 looks ready here. | kaiser | 01/28/2016 1:14:18 PM |
4449 | $ICNV 0024 looks ready for a nice | kaiser | 01/28/2016 10:38:43 AM |
Recent Articles
- Understanding the Impacts of Adani's U.S. Bribery Charges
- Warren Buffett's Essential Advice for Parents on Inheritance
- Kronos Bio Welcomes New Leadership Amid Major Changes
- Prelude Therapeutics Engages in Key Hematology Summit Events
- Growth of Perineal Care Market: Predictions and Insights
- Exploring the Future of Autonomous Construction Equipment
- The Future of Commerce Cloud: Booming Growth Ahead
- Bitcoin's $93,000 Movement: Is a Bullish Trend Forming?
- FlexShopper Plans Innovative Rights Offering for Shareholders
- Y-mAbs Therapeutics: Engaging at 2024 Global Healthcare Event
- CrowdStrike Experiences Unanticipated Stock Drop Despite Growth
- Dragonfly Energy's New Battery Launch Amid Market Pressures
- Dan Ives Analyzes the Musk vs. Newsom Dispute and Its Risks
- Top Analysts Weigh In on Three High-Dividend Real Estate Stocks
- NIO's Strategic Expansion and Stock Performance Update
- Grant Cardone Warns of Housing Crisis Amid Rising Mortgage Rates
- MCF Energy Updates on Welchau-1 and Kinsau-1A Developments
- Carisma Therapeutics Engages with Investors at HealthCONx Conference
- Tower Bridge Funding's Vida Bank License and Name Change
- JPMorgan Global Growth & Income PLC Expands Share Issuance
- Alumasc Group's Upcoming Half-Year Financial Update Insights
- Symbotic Faces Setback with Stock Plunge Following Filing Delay
- Apple’s iPhone Sales Face Major Drop in China Market
- Spirits Industry Advocates for Tariff Exemptions Amid Challenges
- Symbotic Faces Challenges with Revenue Recognition Errors
- Ocugen's CEO to Share Insights at NobleCon20 Event Soon
- Class Action Opportunities for Wolfspeed, Inc. Investors
- CT Real Estate Investment Trust Launches New Unit Purchase Program
- RADCOM's Insights on 5G Network Intelligence Solutions
- Power Nickel Welcomes Jon Christian Evensen as Strategic Advisor
- Urano Energy Expands Portfolio with New Uranium Acquisitions
- Celebrating Innovations in Cellular Agriculture at CULT Food Science
- Codere Online's Impressive Growth in Q3 2024 Financials
- CollPlant Biotechnologies: Q3 2024 Financial Insights and Growth
- NurExone's Latest Financial Insights and New Growth Strategies
- Arbe Robotics Reports Third Quarter Financial Growth and Outlook
- Antofagasta's New Chair Elevates Sustainability Commitment
- Laser Photonics Revolutionizes Surface Treatment with New Laser
- PTC Therapeutics Secures $150 Million from PRV Sale Celebration
- WW International Welcomes New CFO to Drive Strategic Growth
- TransCode Therapeutics Secures Funding to Enhance Cancer Research
- enCore Energy's Transition to U.S. Filing and Recent Developments
- Smurfit Westrock's Successful Green Bonds Raise €1.2 Billion
- Medicenna Therapeutics Unveils New ABILITY-1 Study Findings
- CervoMed Receives Orphan Drug Designation for Dementia Treatment
- Aston Martin Faces Profit Challenges While Seeking New Capital
- JPMorgan Predicts Extended Market Polarization Through 2025
- Aston Martin Revises Profit Expectations Amid Challenges
- Dell and HP's Harsh Forecasts Trigger PC Market Concerns
- Understanding Gold Price Movements amid Economic Uncertainty